ASX - Delayed Quote AUD

Arovella Therapeutics Limited (ALA.AX)

Compare
0.1900
+0.0050
+(2.70%)
At close: 3:55:02 PM GMT+11
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
17.0000
17.0000
405.8980
295.8100
257.3470
Cost of Revenue
--
--
203.5200
207.0560
222.7500
Gross Profit
17.0000
17.0000
202.3780
88.7540
34.5970
Operating Expense
10,828.2610
10,828.2610
9,883.1170
7,685.1960
4,700.7120
Operating Income
-10,811.2610
-10,811.2610
-9,680.7390
-7,596.4420
-4,666.1150
Net Non Operating Interest Income Expense
130.1040
130.1040
9.3460
-190.8750
-26.7520
Other Income Expense
1,935.1220
1,935.1220
-509.9580
-833.2710
-354.5980
Pretax Income
-8,746.0350
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Net Income Common Stockholders
-8,746.0350
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Basic EPS
-0.01
--
-0.01
-0.02
-0.02
Diluted EPS
-0.01
--
-0.01
-0.02
-0.02
Basic Average Shares
941,423.3560
--
711,483.4010
549,623.8380
330,893.2810
Diluted Average Shares
941,423.3560
--
711,483.4010
549,623.8380
330,893.2810
Net Income from Continuing & Discontinued Operation
-8,746.0350
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Normalized Income
-8,746.0350
-8,746.0350
-8,622.6300
-7,787.3170
-3,786.1970
Interest Income
138.7350
138.7350
30.0200
3.8450
6.5420
Interest Expense
8.6310
8.6310
20.6740
194.7200
33.2940
Net Interest Income
130.1040
130.1040
9.3460
-190.8750
-26.7520
EBIT
-8,737.4040
-8,737.4040
-10,160.6770
-8,425.8680
-5,014.1710
EBITDA
-8,694.4250
-8,694.4250
-9,323.5000
-7,874.3800
-4,361.9950
Reconciled Cost of Revenue
--
--
203.5200
207.0560
222.7500
Reconciled Depreciation
42.9790
42.9790
837.1770
551.4880
652.1760
Net Income from Continuing Operation Net Minority Interest
-8,746.0350
-8,746.0350
-10,181.3510
-8,620.5880
-5,047.4650
Total Unusual Items Excluding Goodwill
--
--
-1,558.7210
-833.2710
-1,261.2680
Total Unusual Items
--
--
-1,558.7210
-833.2710
-1,261.2680
Normalized EBITDA
-8,694.4250
-8,694.4250
-7,764.7790
-7,041.1090
-3,100.7270
6/30/2021 - 1/22/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1AI.AX Algorae Pharmaceuticals Limited
0.0060
-14.29%
 
1AD.AX AdAlta Limited
0.0170
0.00%
 
ANR.AX Anatara Lifesciences Ltd
0.0510
+6.25%
 
ACR.AX Acrux Limited
0.0330
+3.12%
 
AGN.AX Argenica Therapeutics Limited
0.6950
+6.11%
 
ADO.AX AnteoTech Limited
0.0180
0.00%
 
TYP.AX TRYPTAMINE FPO [TYP]
0.0370
+19.35%
 
ACW.AX Actinogen Medical Limited
0.0270
0.00%
 
CMB.AX Cambium Bio Limited
0.3900
0.00%
 
AVE.AX Avecho Biotechnology Limited
0.0040
+33.33%